Oct 9 (Reuters) - Pfizer Inc (NYSE:PFE) PFE.N and Germany's BioNTech SE 22UAy.F said on Friday they have started a rolling submission to Health Canada for their experimental COVID-19 vaccine.
The companies said under the rolling submission they would submit safety and efficacy data from trial of their COVID-19 vaccine to Canada's health ministry as and when it becomes available.